Article

CIGB-300 synthetic peptide, an antagonist of CK2 kinase activity, as a treatment for Covid-19. A computational biology approach

2021-07-26

Abstract excerpt

Drug repositioning became the first choice for treating Covid-19 patients due to the urgent need to deal with the pandemic. Similarities in the hijacking mechanisms used by SARS-CoV-2 and several type of cancer, suggest the repurposing of cancer drugs to treat Covid-19. CK2 kinase antagonists have been proposed for the treatment of cancer. A recent study in cells infected with SARS-CoV-2 virus found a significant...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 312ce697-84a2-5f31-919c-a5f7f101d140
DOI: 10.1101/2021.07.26.453805

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

CIGB-300 synthetic peptide, an antagonist of CK2 kinase activity, as a treatment for Covid-19. A computational biology approachDOI 10.1101/2021.07.26.453805Read

CIGB-300 Synthetic Peptide, an Antagonist of CK2 Kinase Activity, as a Treatment for Covid-19. A Computational Biology ApproachSemantic proximity Read

Protein kinase CK2: a potential therapeutic target for diverse human diseases.Semantic proximity Read

Safeguarding COVID-19 and cancer management: drug design and therapeutic approachSemantic proximity Read

Potential Therapeutic Agents and Associated Bioassay Data for COVID-19 and Related Human Coronavirus InfectionsSemantic proximity Read

Host kinase CSNK2 is a target for inhibition of pathogenic β-coronaviruses including SARS-CoV-2Semantic proximity Read

Drug-repurposing against COVID-19 by targeting a key signaling pathway: An in silico studySemantic proximity Read

Role and mechanistic actions of protein kinase inhibitors as an effective drug target for cancer and COVIDSemantic proximity Read

Global multi-omics and systems pharmacological strategy unravel the multi-targeted therapeutic potential of natural bioactive molecules against COVID-19: An in silico approachSemantic proximity Read

Polypharmacology is an enduring and nearly universal property of kinase inhibitorsSemantic proximity Read

Molecular Pathways: Emergence of Protein Kinase CK2 (CSNK2) as a Potential Target to Inhibit Survival and DNA Damage Response and Repair Pathways in Cancer CellsSemantic proximity Read

CMGC Kinases in Health and CancerSemantic proximity Read

High neutrophils and triglycerides lead to critical illness in COVID-19 and reveal CDK6 inhibitors as potential treatmentSemantic proximity Read